Last updated: 2026-09-16 10:32:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Medifast, Inc. (MED) operates in the MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS sector and is listed on NYSE. The stock is currently priced at $11.99, with a market capitalisation of $134.17M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.22 to $14.67. This page covers its latest market performance, valuation, price trends and company information.
$134.17M | |
$12.04 | |
$336.99 | |
$2.58 | |
$12.00 | |
59.72K | |
201.20K | |
-- | |
$14.67 | |
$9.22 | |
0.13% | |
-- |
Medifast, Inc. (MED) is trading at $12.24 in pre-market trading as of 2026-09-15 23:31:00, up 2.00% ($0.24) from the previous close of $12.00
Pre-market trading shows how investors are pricing MED before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Medifast, Inc. (MED) moved from $12.63 to $11.99, representing a decline of 5.04% ($0.64).
The stock traded between $11.80 and $12.66 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 69.18 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 50.9%
MED is currently trading at $11.99, placing it 50.9% of the way from its 52-week low of $9.22 to its 52-week high of $14.67. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
| Industry | MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS |
| Employees | 380 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Medifast, Inc. (MED) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.